Breast cancer risk after diagnosis by screening mammography of nonproliferative or proliferative benign breast disease: a study from a population-based screening program


Por: Castells, X, Domingo, L, Corominas, JM, Tora-Rocamora, I, Quintana, MJ, Bare, M, Vidal, C, Natal, C, Sanchez, M, Saladie, F, Ferrer, J, Vernet, M, Servitja, S, Rodriguez-Arana, A, Roman, M, Espinas, JA, Sala, M

Publicada: 1 ene 2015
Resumen:
Benign breast disease increases the risk of breast cancer. This association has scarcely been evaluated in the context of breast cancer screening programs although it is a prevalent finding in mammography screening. We assessed the association of distinct categories of benign breast disease and subsequent risk of breast cancer, as well as the influence of a family history of breast cancer. A retrospective cohort study was conducted in 545,171 women aged 50-69 years biennially screened for breast cancer in Spain. The median of follow-up was 6.1 years. The age-adjusted rate ratio (RR) of breast cancer for women with benign breast disease, histologically classified into nonproliferative and proliferative disease with and without atypia, compared with women without benign breast disease was estimated by Poisson regression analysis. A stratified analysis by family history of breast cancer was performed in a subsample. All tests were two-sided. The age-adjusted RR of breast cancer after diagnosis of benign breast disease was 2.51 (95 % CI: 2.14-2.93) compared with women without benign breast disease. The risk was higher in women with proliferative disease with atypia (RR = 4.56, 95 % CI: 2.06-10.07) followed by those with proliferative disease without atypia (RR = 3.58; 95 % CI = 2.61-4.91). Women with nonproliferative disease and without a family history of breast cancer remained also at increased risk of cancer (OR = 2.23, 95 % CI: 1.86-2.68). An increased risk of breast cancer was observed among screening participants with proliferative or nonproliferative benign breast disease, regardless of a family history of breast cancer. This information may be useful to explore risk-based screening strategies.

Filiaciones:
Castells, X:
 Hosp del Mar Med Res Inst IMIM, Dept Epidemiol & Evaluat, Pg Maritim 25-29, Barcelona 08003, Catalonia, Spain

 Res Network Hlth Serv Chron Dis REDISSEC, Barcelona, Spain

Domingo, L:
 Hosp del Mar Med Res Inst IMIM, Dept Epidemiol & Evaluat, Pg Maritim 25-29, Barcelona 08003, Catalonia, Spain

 Res Network Hlth Serv Chron Dis REDISSEC, Barcelona, Spain

Corominas, JM:
 Hosp del Mar Med Res Inst IMIM, Barcelona 08003, Catalonia, Spain

Tora-Rocamora, I:
 Hosp del Mar Med Res Inst IMIM, Dept Epidemiol & Evaluat, Pg Maritim 25-29, Barcelona 08003, Catalonia, Spain

 Res Network Hlth Serv Chron Dis REDISSEC, Barcelona, Spain

Quintana, MJ:
 Hosp Santa Creu & Sant Pau, Dept Epidemiol, Barcelona, Catalonia, Spain

Bare, M:
 Res Network Hlth Serv Chron Dis REDISSEC, Barcelona, Spain

 Parc Tauli Univ Hosp, Sabadell, Catalonia, Spain

Vidal, C:
 Catalan Inst Oncol, Canc Prevent & Monitoring Programme, Barcelona, Catalonia, Spain

 Principal Asturias, Principal Asturias Breast Canc Screening Programm, Oviedo, Spain

Sanchez, M:
 Govt Cantabria, Dept Hlth, Direct Gen Publ Hlth, Santander, Cantabria, Spain

Saladie, F:
 Fdn League Res & Prevent Canc, Breast Canc Screening Programme Tarragona, Tarragona, Catalonia, Spain

Ferrer, J:
 Hosp Santa Caterina, Dept Radiol, Girona, Catalonia, Spain

Vernet, M:
 Hosp del Mar Med Res Inst IMIM, Barcelona 08003, Catalonia, Spain

Servitja, S:
 Hosp del Mar Med Res Inst IMIM, Barcelona 08003, Catalonia, Spain

Rodriguez-Arana, A:
 Hosp del Mar Med Res Inst IMIM, Barcelona 08003, Catalonia, Spain

Roman, M:
 Hosp del Mar Med Res Inst IMIM, Dept Epidemiol & Evaluat, Pg Maritim 25-29, Barcelona 08003, Catalonia, Spain

 Res Network Hlth Serv Chron Dis REDISSEC, Barcelona, Spain

Espinas, JA:
 Catalan Canc Plan, Dept Hlth, Catalonia, Spain

 Carlos III Hlth, Spanish Canc Res Network RTICC, Madrid, Spain

Sala, M:
 Hosp del Mar Med Res Inst IMIM, Dept Epidemiol & Evaluat, Pg Maritim 25-29, Barcelona 08003, Catalonia, Spain

 Res Network Hlth Serv Chron Dis REDISSEC, Barcelona, Spain
ISSN: 01676806





BREAST CANCER RESEARCH AND TREATMENT
Editorial
SPRINGER, ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES, Estados Unidos America
Tipo de documento: Article
Volumen: 149 Número: 1
Páginas: 237-244
WOS Id: 000348183700025
ID de PubMed: 25503778
imagen Green Published, hybrid

MÉTRICAS